Breast and Ovarian Cancer, HBOC, Familial (17 genes)

Genetic test Export to PDF
Full name:
Breast and Ovarian Cancer, HBOC, Familial (17 genes)
Test type:
Clinical
Test specialty:
Molecular Genetics
Test purpose:
Mutation confirmation,
Post-natal Diagnosis,
Pre-implantation genetic diagnosis,
Predictive and Pre-symptomatic diagnosis,
Somatic genetics,
Therapeutic Management
Specimen:
Peripheral (whole) blood on EDTA,
DNA
Method category:
Method technique:
Laboratory:
RIZIV code:
EQA:
  • 2015 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2016 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2017 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2018 Familial Breast/Ovarian Cancer (full version) EMQN
  • 2019 Hereditary Breast and Ovarian Cancer (Panel) EMQN
  • 2022 Hereditary Breast and Ovarian Cancer (panel testing) EMQN
Accreditation (ISO 15189):
2022-12-22 / 2027-12-21
Turnaround time (maximum):
3 months
Document(s):
Created:
24 Jul 2019 - 11:48
Changed:
24 Jan 2023 - 14:47